These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4973676)

  • 1. [Experimental research on the antimycobacterial activity of rifampicine: 3-(4-methyl-l-piperazinyl-iminomethyl)-rifomycin SV].
    Lucchesi M; Mancini P; Zubiani M
    Ann Ist Carlo Forlanini; 1967; 27(2):119-36. PubMed ID: 4973676
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies of the antimycobacterial activity of Rifampicine].
    Nitti V; Catena E; Ninni A; Di Filippo A
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):867-910. PubMed ID: 4969274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental investigations of bacteriological mechanisms in short course chemotherapy.
    Dickinson JM; Mitchison DA
    Bull Int Union Tuberc; 1976; 51(1):79-86. PubMed ID: 829484
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antimycobacterial activity of rifomycin: in vitro and in vivo studies].
    Tacquet A; Devulder B; Martin JC; Daniel H; Le Bouffant L
    Acta Tuberc Pneumol Belg; 1969; 60(3):366-89. PubMed ID: 5371669
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of rifampicin on experimental mouse tuberculosis].
    Yoshida F
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):35-43. PubMed ID: 4990960
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antimycobacterial activity of rifomycin in vitro in various media].
    Hennebert A
    Acta Tuberc Pneumol Belg; 1969; 60(3):348-55. PubMed ID: 4984418
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimycobacterial activity of rifampicin.
    Lucchesi M; Mancini P
    Antibiot Chemother; 1970; 16():431-43. PubMed ID: 5002307
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V; Ninni A; Natali P
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood, tissue and lesion levels of R AMP in the guinea pig infected with Mycobacterium tuberculosis].
    Blasi A; Ninni A; Olivieri D; Caputi M
    G Ital Mal Torace; 1971; 25(6):283-7. PubMed ID: 5005061
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance of tubercle bacilli to rifampicin in experimental tuberculosis induced in laboratory animals].
    Janowiec M; Wierzejska H
    Gruzlica; 1973 Mar; 41(3):251-7. PubMed ID: 4633122
    [No Abstract]   [Full Text] [Related]  

  • 15. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 16. [An experimental study on the antituberculous activity of rifampicin].
    Toyoara M
    Kekkaku; 1971 Jun; 46(6):211-6. PubMed ID: 4997827
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA.
    Dutta NK; Mazumdar K; Dastidar SG; Chakrabarty AN; Shirataki Y; Motohashi N
    In Vivo; 2005; 19(3):539-45. PubMed ID: 15875773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intermittent rifomycin therapy of experimental tuberculosis in guinea pigs].
    Daddi G; Lucchesi M; Mancini P
    Ann Ist Carlo Forlanini; 1968; 28(4):354-68. PubMed ID: 5738472
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifomycin in treatment of tuberculosis with polyresistant mycobacteria: clinical and laboratory observations].
    Daddi G; Lucchesi M
    Acta Tuberc Pneumol Belg; 1969; 60(3):442-9. PubMed ID: 4984423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental aspects of the antimycobacterial activity of rifampicin].
    Blasi A; Di Perna A; Vinciguerra E
    Arch Tisiol Mal Appar Respir; 1967 Nov; 22(11):943-66. PubMed ID: 4978601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.